MUMBAI, India, June 22 -- Intellectual Property India has published a patent application (202621048934 A) filed by Indian Institute Of Technology Bombay on April 17, 2026, for Metabolic Markers Of Cisplatin Resistance In Triple-Negative Breast Cancer (tnbc).
Inventors include Parihari, Shashwati; and Srivastava, Sanjeeva.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: Provided herein is a method for screening differential expression of metabolic biomarkers in cisplatin-resistant TNBC cells compared to sensitive sample. The biomarkers are selected from the group consisting of sphinganine-1-phosphate, sphingosine, ceramide, phytosphingosine, lysophosphatidylcholine (LysoPC), arginine, thre...